The field of focused ultrasound is growing more rapidly and having more of an impact than any of us ever could have imagined.
The success we’ve had to date is a result of the entire focused ultrasound community’s efforts. Thank you all for working toward a common goal of making this technology widely available as a standard of care in the shortest time possible.
In 2018, focused ultrasound for Alzheimer's disease reached important milestones. Results of a landmark trial in Toronto using focused ultrasound to open the blood-brain barrier (BBB) in Alzheimer’s patients were published in Nature Communications. In October, researchers at West Virginia University began a similar clinical trial, but notably the first-ever US trial utilizing focused ultrasound for Alzheimer’s disease.
Focused ultrasound earned FDA approval to treat Parkinson's disease patients for whom tremor is their primary symptom.
We are continuing to explore the role of focused ultrasound for immune-based cancer treatments through several partnerships with prominent organizations in the field.
Additionally, there are clinical trials are underway for neuropathic pain, epilepsy, pancreatic cancer, and many other diseases.
We partnered with the Consumer Technology Association's "Let's Go Humans" campaign to release an impactful video featuring Julia, an essential tremor patient.
The Foundation's media coverage reached new heights in 2018, with more than 500 news stories featuring the technology.
Our 6th International Symposium attracted a record number of attendees and scientific presentations on the latest research in the field of focused ultrasound.
The Foundation also released the 2018 State of the Field Report and announced a partnership with the Medical Imaging & Technology Alliance to raise awareness of focused ultrasound among policymakers, insurance payors, and specialty societies.
The Foundation met a generous $10 million matching gift in November.
We continue to hold the highest rankings on Charity Navigator and Guidestar – online tools that assess nonprofits' financial and organizational transparency – and we were recognized as one of Charity Navigator’s 10 Best Medical Research Organizations in America.
Your generosity enables us to fund groundbreaking research, convene the best minds to overcome barriers, and spread the word about the immense potential of focused ultrasound. We thank you for your support and the important role you play in advancing this technology that could one day impact millions.
We use cookies to optimize our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
By using FUSF’s AI agent, you acknowledge and agree that your use is governed by FUSF’s Terms of Use Agreement. If you do not agree to be bound by the Terms of Use Agreement, you may not access or use FUSF’s AI agent.
